Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

被引:930
作者
Borrow, P
Lewicki, H
Wei, XP
Horwitz, MS
Peffer, N
Meyers, H
Nelson, JA
Gairin, JE
Hahn, BH
Oldstone, MBA
Shaw, GM
机构
[1] OREGON HLTH SCI UNIV, DEPT MOL MICROBIOL & IMMUNOL, PORTLAND, OR 97201 USA
[2] CNRS, UPR 9021, INST PHARMACOL & BIOL STRUCT, F-31077 TOULOUSE, FRANCE
[3] UNIV ALABAMA, DEPT MED, DIV HEMATOL ONCOL, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1038/nm0297-205
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV-1-specific cytotoxic T lymphocyte (CTL) response is temporally associated with the decline in viremia during primary HIV-1 infection, but definitive evidence that it is of importance in virus containment has been lacking. Here we show that in a patient whose early CTL response was focused on a highly immunodominant epitope in gp160, there was rapid elimination of the transmitted virus strain and selection for a virus population bearing amino acid changes at a single residue within this epitope, which conferred escape from recognition by epitope-specific CTL. The magnitude (>100-fold), kinetics (30-72 days from onset of symptoms) and genetic pathways of virus escape from CTL pressure were comparable to virus escape from antiretroviral therapy, indicating the biological significance of the CTL response in vivo. One aim of HIV-1 vaccines should thus be to elicit strong CTL responses against multiple codominant viral epitopes.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 39 条
[1]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[2]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[3]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[4]   IMPAIRED CYTOTOXIC T-LYMPHOCYTE RECOGNITION DUE TO GENETIC VARIATIONS IN THE MAIN IMMUNOGENIC REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 NEF PROTEIN [J].
COUILLIN, I ;
CULMANNPENCIOLELLI, B ;
GOMARD, E ;
CHOPPIN, J ;
LEVY, JP ;
GUILLET, JG ;
SARAGOSTI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1129-1134
[5]  
DESTGROTH SF, 1982, J IMMUNOL METHODS, V49, P11
[6]  
Flynn JN, 1996, J IMMUNOL, V157, P3658
[7]   OPTIMAL LYMPHOCYTIC CHORIOMENINGITIS VIRUS SEQUENCES RESTRICTED BY H-2D(B) MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES AND PRESENTED TO CYTOTOXIC T-LYMPHOCYTES [J].
GAIRIN, JE ;
MAZARGUIL, H ;
HUDRISIER, D ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2297-2305
[8]   EARLY SUPPRESSION OF SIV REPLICATION BY CD8+ NEF-SPECIFIC CYTOTOXIC T-CELLS IN VACCINATED MACAQUES [J].
GALLIMORE, A ;
CRANAGE, M ;
COOK, N ;
ALMOND, N ;
BOOTMAN, J ;
RUD, E ;
SILVERA, P ;
DENNIS, M ;
CORCORAN, T ;
STOTT, J ;
MCMICHAEL, A ;
GOTCH, F .
NATURE MEDICINE, 1995, 1 (11) :1167-1173
[9]  
Harrer T, 1996, J IMMUNOL, V156, P2616
[10]   RAPID TURNOVER OF PLASMA VIRIONS AND CD4 LYMPHOCYTES IN HIV-1 INFECTION [J].
HO, DD ;
NEUMANN, AU ;
PERELSON, AS ;
CHEN, W ;
LEONARD, JM ;
MARKOWITZ, M .
NATURE, 1995, 373 (6510) :123-126